The markets rallied again today after a strong consumer sentiment report was released this morning. The Dow Jones Industrial Average (DJINDICES: ^DJI ) rose 121 points or 0.8% and now sits at 15,354, but even with that impressive gain, the Dow was the worst performing index. The S&P 500 was the best, as it increased by 1.03% during the regular trading session while the NASDAQ rose higher by 0.97%.
The Thomson Reuter/University of Michigan preliminary consumer sentiment index for May rose to 83.7, while analysts were only expecting an increase to 77.9 after April's reading came in at 76.4. Furthermore, this is the highest the index has been since July 2007. But, despite the consumer index climbing higher, a number of the Dow's consumer facing stocks fell this afternoon. �
Top 10 Information Technology Stocks To Watch For 2015: Perrigo Company PLC (PRGO)
Perrigo Company plc, incorporated on March 23, 1988, is a global healthcare supplier that develops, manufactures and distributes over-the-counter (OTC) and generic prescription (Rx) pharmaceuticals, infant formulas, nutritional products, animal health, dietary supplements, active pharmaceutical ingredients (API), and medical diagnostic products, and Multiple Sclerosis drug Tysabri. The Company�� businesses include Consumer Healthcare, Nutritionals, Rx Pharmaceuticals, API, Life Sciences and Other Businesses. The Company offers Healthcare Products across a range of product categories primarily in the United States, the United Kingdom, Mexico, Israel and Australia, and distributes into dozens of other markets worldwide, including Canada, China and Latin America. In February 2014, the Company announced that it has acquired a basket of value-brand OTC products sold in Australia and New Zealand from Aspen Global Inc.
The Company operates through several wholly owned subsidiaries. In the United States, its operations are conducted primarily through L. Perrigo Company, Perrigo Company of South Carolina, Inc., Perrigo New York, Inc., PBM Products, LLC, PBM Nutritionals, LLC, Paddock Laboratories, LLC, Perrigo Diabetes Care, LLC (formerly CanAm Care, LLC), Sergeant's Pet Care Products, Inc. and Fidopharm, Inc. Outside the United States, its operations are conducted primarily through Perrigo Israel Pharmaceuticals Ltd., Chemagis Ltd., Quimica y Farmacia S.A. de C.V., Laboratorios Diba, S.A., Wrafton Laboratories Limited, Galpharm Healthcare Ltd., Orion Laboratories Pty Ltd and Rosemont Pharmaceuticals Ltd.
Consumer Healthcare
Perrigo Consumer Healthcare (CHC) operation includes the Company's United States, United Kingdom and Mexico manufacturing operations supporting the sale of OTC pharmaceutical products. Perrigo CHC supplies more than 15 categories and 500 formulas and offers analgesics, cough and cold remedies, and gastrointestinal and feminine hygiene products, as w! ell as vitamins, dietary supplements and nutritional drinks. Perrigo offers a range of products, such advertised brand products as Tylenol, Advil or One-A-Day. Tylenol has acetaminophen as an active ingredient and is available in stores' analgesic (pain reliever) aisle. Store-brand acetaminophen is located next to the national brand, offering the same active ingredient (acetaminophen) and the same pain relief.
Perrigo Nutritionals
Perrigo is a manufacturer of nutrition products for the store brand market. Nutrition products include infant formula, pediatric nutritionals and vitamins, minerals, and supplements. Acquired by Perrigo, Perrigo Nutritionals, formerly PBM Products, LLC, had introduced private-label, or store-brand infant formulas to the United States. Perrigo Nutritionals is the supplier of store-brand infant formulas and nutrition products. With distribution to major retailers, Perrigo Nutritional products can be found in more than 40,000 retail locations around the world. Its pediatric nutritionals business extends its offerings to children well beyond infancy. Its baby cereals, toddler foods, and pediatric nutritional drinks are available as store brands at various retail locations throughout the United States and the international community. Perrigo manufactures a range of vitamins, minerals, and supplements, in every major segment of the business. Marketed under the store brand labels of the retailers in the food, drug, mass-merchandise and wholesale club channels, it manufactures over 395 formulas of dietary supplements. Its brands include Centrum, One-A-Day, Flintstones, and Osteo-Bi-Flex.
Rx Pharmaceuticals
The Company�� Rx Pharmaceuticals business is focused on the development, manufacture and sale of generic prescription drug products, primarily for the United States market. Manufacturing operations are based in the United States and Israel. Perrigo's portfolio focuses on complex, high-barrier ophthalmological, topical foam and or! al liquid! formulations. Its products include Acetylcysteine Injection 200 mg/mL (6g/30mL), Acetylcysteine Injection 6 g/30 mL (200 mg/1 mL), NOVAPLUS, ACTIDOSE with SORBITOL, ACTIDOSE-AQUA, ASPIRIN SUPPOSITORIES USP, Bacitracin Ophthalmic Ointment USP, Belladonna and Opium Suppositories C-II, BENZOIN COMPOUND TINCTURE USP, Benzoyl Peroxide 10% Acne Medication Wash, CLOBETASOL PROPIONATE LOTION 0.05% and Docusate Sodium.
Active Pharmaceutical Ingredients
Primarily through the Company�� Israel-based business, Perrigo develops, manufactures and markets the complex chemicals and active pharmaceutical ingredients used worldwide by the generic drug industry. Certain of these ingredients are also used in Perrigo's own pharmaceutical products. It manufactures API at facilities in Israel, India and China. Perrigo API specializes in tailor-made research and process development of APIs and Finished Dosage Forms (FDFs).
Life Sciences
Through the Company�� Israel-based business, Perrigo markets and manufactures branded prescription drugs and medical diagnostic products through exclusive agreements with pharmaceutical companies. Its Pharmaceutical and Medical Diagnostic Products businesses also market and manufacture branded prescription drugs under licenses. Other pharmaceutical and medical diagnostics products are imported to Israel through exclusive agreements. Products in life sciences segment include TYSABRI and ELND005. TYSABRI (natalizumab) is indicated for treatment of: Multiple Sclerosis: as monotherapy for the treatment of patients with relapsing forms of multiple sclerosis to delay the accumulation of physical disability and reduce the frequency of clinical exacerbations. TYSABRI is recommended for patients who have had an inadequate response to, or are unable to tolerate, an alternate MS therapy; Crohn�� Disease (CD): Inducing and maintaining clinical response and remission in adult patients with moderately to severely active Crohn�� disease with e! vidence o! f inflammation who have had an inadequate response to, or are unable to tolerate, conventional CD therapies and inhibitors of tumor necrosis factor-伪.
Other
Perrigo's Pharmaceutical and Medical Diagnostic Products business markets and manufactures branded prescription drugs under licenses. Other pharmaceutical and medical diagnostic products are imported to Israel through exclusive agreements with pharmaceutical and diagnostics companies. This business is divided into two departments: Pharma-Israel and Tayco Diagnostics. Pharma-Israel operates in the Israeli market as a partner in the marketing, sales and distribution of Rx (dermatology, gastroenterology, blood products, CNS, urology and other fields), OTC, generics, branded generics, dermo-cosmetics and dietary supplements. Tayco, the diagnostics division of Perrigo-Israel Pharmaceuticals Ltd., specializes in marketing and sales of medical laboratory systems, reagents, accessories and consumables. It also markets self-monitoring medical devices for diagnosis and treatment of diabetes. The division operates throughout Israel to service the central laboratory, hospital, clinic, point of care and self-testing markets. Its activities in the medical and research fields in Israel cover all market segments: medical (private and public health services), research institutions and the biotech industry.
The Company competes with Dr. Reddy�� Laboratories, Ltd., Actavis Inc., Aaron Industries, Inc., Ohm Laboratories, Inc., PL Developments, LNK International, Inc., Abbott Laboratories, Mead Johnson Nutrition Co., Nestle S.A. (Gerber), Danone Baby Nutrition, Bayer AG, Pfizer, Inc., Rexall Sundown, Inc., Apotex, Glenmark Generics Inc., Impax, Prasco, Sandoz, Taro Pharmaceuticals, Teva Pharmaceutical Industries Ltd., Triax Pharmaceuticals, and Zydus Pharmaceuticals.
Advisors' Opinion:- [By Rich Duprey]
Investors going with health-care products maker Perrigo� (NYSE: PRGO ) �will receive a�quarterly cash dividend�of�$0.09 per share on June 18 to shareholders of record at the close of business on May 31 for the fiscal third quarter of 2013.
- [By Rich Duprey]
Generic pharmaceutical manufacturer Perrigo (NYSE: PRGO ) announced today its third-quarter dividend of $0.09 per share, the same rate it's paid for the past three quarters after raising the payout 12.5% from $0.08 per share.
Top 5 Performing Stocks To Own Right Now: United States 12 Month Oil Fund LP (USL)
The United States 12 Month Oil Fund, LP (US12OF) is a commodity pool that issues limited partnership interests traded on the New York Stock Exchange (NYSE) Arca, Inc. (the NYSE Arca). The investment objective of US12OF is for the daily changes in percentage terms of its units per unit net asset value (NAV) to reflect the daily changes in percentage terms of the spot price of light, sweet crude oil delivered to Cushing, Oklahoma, as measured by the changes in the average of the prices of 12 futures contracts for light, sweet crude oil traded on the New York Mercantile Exchange (the NYMEX) consisting of the near month contract to expire and the contracts for 11 months, for a total of 12 consecutive months contracts, except when the near month contract is within two weeks of expiration, in which case it is measured by the futures contract that is the next month contract to expire and the contracts for 11 consecutive months (the Benchmark Oil Futures Contracts). The Company is managed and controlled by its general partner, United States Commodity Funds LLC (the General Partner). The General Partner is the general partner of US12OF and is responsible for the management of US12OF.
The net assets of US12OF consist primarily of investments in futures contracts for light, sweet crude oil, other types of crude oil, heating oil, gasoline, natural gas, and other petroleum-based fuels that are traded on the NYMEX, ICE Futures or other United States and foreign exchanges (collectively, Oil Futures Contracts). It also invests in other oil interests, such as cash-settled options on Oil Futures Contracts, forward contracts for oil, cleared swap contracts and non-exchange traded (over-the-counter) transactions that are based on the price of oil, other petroleum-based fuels, Oil Futures Contracts and indices based on the foregoing (collectively, Other Oil-Related Investments). For convenience and unless otherwise specified, Oil Futures Contracts and Other Oil-Related Investments collectively are referred to! as oil Interests.
US12OF invests in Oil Interests to the fullest extent possible without being leveraged or unable to satisfy its current or potential margin or collateral obligations with respect to its investments in Oil Futures Contracts and Other Oil-Related Investments. US12OF�� investments in short-term obligations of the United States of two years or less (Treasuries), cash and/or cash equivalents.
Advisors' Opinion:- [By Dan Caplinger]
Another choice is to use ETFs with a longer-term futures strategy. The United States 12-Month Oil Fund (NYSEMKT: USL ) holds equal positions in each of the next 12 futures contracts. That reduces the positive impact of near-term backwardation, but it gives you more exposure to the heavier backwardation that exists further into the future.
Top 5 Performing Stocks To Own Right Now: Barrett Business Services Inc.(BBSI)
Barrett Business Services, Inc. provides business management solutions in the United States. The company offers human resource management services in areas comprising payroll processing, employee benefits and administration, human resource management, risk management, and workers? compensation coverage areas. It also provides professional employer organization services, which include employee benefits, health insurance, workers? compensation coverage, workplace safety programs, federal and state employment laws compliance, labor and workplace regulatory requirements, and related administrative services; and payroll administrative services, such as payroll processing, payroll taxes, and human resource consulting services. In addition, the company provides staffing services, including on-demand or short-term staffing assignments, contract staffing, long-term or indefinite-term on-site management, direct placement, and human resource administration services. It serves elect ronics manufacturers; various light-manufacturing industries; forest products and agriculture-based companies; transportation and shipping enterprises; food processing; telecommunications; public utilities; general contractors in various construction-related fields; and professional services firms. Barrett Business Services, Inc. was founded in 1965 and is headquartered in Vancouver, Washington.
Advisors' Opinion:- [By Rich Duprey]
The much smaller Barrett Business Services (NASDAQ: BBSI ) has done even better, soaring 154% over the last 12 months.
While that might suggest the opportunity to invest in them has passed, I believe their biggest gains are still ahead. While tentativeness among employers about whether the economy is really improving is helping employers to hire more temp workers, the coming implementation of Obamacare will fuel it further. Even with the employer mandate portion of the law being pushed out past the midterm elections to 2015 instead of going into effect on January 1, that just means more companies will be hiring more temp workers for a longer period of time to get below the thresholds the health-care law imposes.
Top 5 Performing Stocks To Own Right Now: iShares Russell 2000 Value ETF (IWN)
iShares Russell 2000 Value Index Fund (the Fund) seeks investment results that correspond generally to the price and yield performance of the Russell 2000 Value Index (the Index). The Index measures the performance of the small-capitalization value sector of the United States equity market. It is a subset of the Russell 2000 Index. The Index is a capitalization-weighted index and consists of those companies or portion of a company, with lower price-to-book ratios and lower forecasted growth within the Russell 2000 Index. The Index represents approximately 50% of the total market capitalization of the Russell 2000 Index.
The Fund invests in a representative sample of securities included in the Index that collectively has an investment profile similar to the Index. iShares Russell 2000 Value Index Fund's investment advisor is Barclays Global Fund Advisors.
Advisors' Opinion:- [By John Udovich]
Yesterday, Luna Innovations Incorporated (NASDAQ: LUNA), a rather unusual and innovative small cap stock,�soared some 23.26%���meaning its worth taking a closer look at the stock along with its performance verses the performance of small cap benchmarks like the iShares Russell 2000 Index ETF (NYSEARCA: IWM), the�iShares Russell 2000 Value Index ETF (NYSEARCA: IWN) or the iShares Russell 2000 Growth Index ETF (NYSEARCA: IWO).
- [By John Udovich]
Small cap custom carry and protective solutions stock Forward Industries, Inc (NASDAQ: FORD) jumped 22.51% earlier today as an apparent turnaround continues, meaning its worth taking a closer look at a stock that�� in a decidedly niche area plus look at the performance of potential investment benchmarks like the iShares Russell 2000 Index ETF (NYSEARCA: IWM), iShares Russell 2000 Growth Index ETF (NYSEARCA: IWO) and iShares Russell 2000 Value Index ETF (NYSEARCA: IWN).
No comments:
Post a Comment